Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 4, 2022
Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019François Montastruc, Margaux Lafaurie, Clara Flumian, et al.Fundamental & Clinical Pharmacology|January 29, 2021
Tramadol-induced hypoglycemia: A pharmacovigilance studyClaire De Canecaude, Vanessa Rousseau, Agnès Sommet, et al.European Journal of Clinical Pharmacology|June 3, 2020
Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic studyJean-Louis Montastruc, Vanessa Rousseau, Claire de Canecaude, et al.Expert Opinion on Drug Safety|August 16, 2023
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance studyRomain Barus, François Montastruc, Claire de Canecaude, et al.Therapie|May 2, 2020
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in FranceJulien Jacquot, Vanessa Rousseau, Claire de Canecaude, et al.Therapie|March 14, 2023
French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)Claire de Canecaude, François Montastruc, Sandrine Bergeron, et al.British Journal of Clinical Pharmacology|May 30, 2020
Can tramadol really induce hyponatraemia? A pharmacovigilance studyClaire de Canecaude, Vanessa Rousseau, Leila Chebane, et al.British Journal of Clinical Pharmacology|April 10, 2021
Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance databaseJean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, et al.Therapie|June 13, 2021
COVID-19 vaccines: A perspective from social pharmacologyJean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, et al.British Journal of Clinical Pharmacology|June 18, 2026
Applying machine learning to pharmacovigilance data: A proof-of-concept studyRomain Barus, Pauline Schiro, Jean-Luc Faillie, et al.Pageof 2